Fujitsu working on a supercomputer for AI research in Japan

The National Institute of Advanced Industrial Science and Technology (AIST) Kashiwa Centre in Japan will soon house a brand-new supercomputer system developed by Fujitsu.

Its AI capacities will be used for research and development by academia, government and industry.

The new supercomputer features 11.2 petabytes of storage capacity, eight NVIDIA A100 high-end GPUs, 120 4U Fujitsu Primergy GX2570 servers, and two third-generation Intel Xeon Scalable processors.

It is said to be able to reach a peak performance of 19.3 petaflops.

The supercomputer will be used in conjunction with AIST’s AI bridging cloud infrastructure (ABCI) system built by Fujitsu and launched in August 2018.

It has been used by various third parties ranging from general electrical appliance manufacturers to start-ups.

According to Fujitsu, “AIST will introduce a new AI bridging green cloud infrastructure system to bolster its existing ABCI, combining a high-performance computing system with a large-capacity storage system while following the basic structure of the ABCI”.

Moreover, the company added that the system’s theoretical peak performance of half-precision floating-point operations comes at 850 petaflops.

Combining its computing capacity with ABCI, double-precision floating-point operations at 56.7 petaflops can be expected.

Thanks to its contribution, Fujitsu will remain a key contributor when it comes to advancing AI research and development in Japan.

The exact launch date of the new supercomputer system still remains unknown, but it is said to be sometime during fiscal 2021.

Fujitsu’s technology plays a vital role in advancing science and research in the country.

To name one example, its Fugaku supercomputer allowed Tokyo Medical and Dental University to run cancer gene analysis in less than a day as opposed to the months that this would otherwise take.

Recently, the firm’s computing prowess has played a key role in crucial matters such as helping the country to make a stand against the ongoing COVID-19 pandemic.